Welcome to QuantumCor, Inc.

QuantumCor is a medical device company developing technologies that will allow physicians to repair the mitral heart valve in a minimally invasive cardiac cath lab procedure, eliminating the need for open heart surgery. 

There are an estimated 3 million patients in the U.S. who suffer from mitral regurgitation.  Since the only treatment available requires open heart surgery, repair is not considered until valve disease has progressed to the point where the patient is significantly symptomatic.  Unfortunately, by that time, many patients are at high risk and are ineligible for surgery. 

Our "disruptive" technology will provide a "Transcatheter", or minimally invasive alternative, for patients facing surgery and will provide a treatment option for high risk patients who are ineligible for surgery.  Additionally, as this is a minimally invasive procedure, we believe physicians will offer mitral valve repair to patients earlier in their disease process before co-morbidities, such as congestive heart failure (CHF) and atrial fibrillation (AF), have compromised their health.